Compounds > n4-(2-2-dimethyl-3-oxo-4h-pyrid(1-4)oxazin-6-yl)-5-fluoro-n2-(3-4-5-trimethoxyphenyl)-2-4-pyrimidinediamine

n4-(2-2-dimethyl-3-oxo-4h-pyrid(1-4)oxazin-6-yl)-5-fluoro-n2-(3-4-5-trimethoxyphenyl)-2-4-pyrimidinediamine and Multiple-Myeloma

n4-(2-2-dimethyl-3-oxo-4h-pyrid(1-4)oxazin-6-yl)-5-fluoro-n2-(3-4-5-trimethoxyphenyl)-2-4-pyrimidinediamine has been researched along with Multiple-Myeloma* in 1 studies

Other Studies

1 other study(ies) available for n4-(2-2-dimethyl-3-oxo-4h-pyrid(1-4)oxazin-6-yl)-5-fluoro-n2-(3-4-5-trimethoxyphenyl)-2-4-pyrimidinediamine and Multiple-Myeloma

ArticleYear
From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration.
    British journal of haematology, 2016, Volume: 174, Issue:6

    Topics: Adult; Aged; Cell Line, Tumor; Cell Movement; Cell Survival; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Multiple Myeloma; Oxazines; Protein Kinase Inhibitors; Pyridines; Syk Kinase

2016